Landex

Quick links to important sections

Landex

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Landex

Landex: Foundational Overview

This section establishes the core identity, composition, and general pharmacological function of the medicine Landex, strictly avoiding details on dosage, specific treatment protocols, or safety information.

Property Description
Active ingredient Donepezil hydrochloride
Form Oral tablets, Orally Disintegrating Tablets (ODTs)
Pharmacological class Acetylcholinesterase Inhibitor (AChEI)
Origin Synthetic compound

What Type of Medicine is Landex?

Landex is a prescription-only medicine whose active component is Donepezil hydrochloride. This substance is a synthetic compound, specifically a piperidine derivative, and is administered via the oral route as solid dosage forms, including film-coated tablets and specialized orally disintegrating tablets (ODTs). The availability of the orally disintegrating tablets is a differentiating factor, offering an alternative administration method compared to standard solid tablets. Landex is formally classified as a centrally acting, reversible Acetylcholinesterase Inhibitor (AChEI), a category that defines its mechanism of action within the central nervous system.

Landex’s Classification and General Purpose

The classification of Landex as an AChEI means it functions by selectively and temporarily blocking the enzyme acetylcholinesterase in the brain. This action directly supports cholinergic neurotransmission by preventing the rapid breakdown of the critical brain chemical acetylcholine. This mechanism is characterized by the maintenance of acetylcholine levels within the central nervous system.

The primary purpose of this mechanism is to increase the concentration and duration of action of acetylcholine at neuronal synapses. This is broadly aimed at supporting fundamental processes related to memory and thinking abilities. As an AChEI, Landex serves to maintain and support cognitive capacity in relevant contexts. This function relates to the medicine's role in supporting brain signaling pathways.

Regulatory References

  1. Label: DONEPEZIL HYDROCHLORIDE tablet, film coated - DailyMed
  2. Donepezil - StatPearls - NCBI Bookshelf - NIH

What side effects are possible with Landex?

Possible Side Effects and Safety Information

The safety profile of Landex (donepezil) is structured by official regulatory agencies, categorizing adverse reactions by the body system affected and their frequency of occurrence as observed in clinical trials.

Adverse Reaction Frequencies

Side effects are often related to the medicine's activity on the cholinergic system and are commonly reported across the Gastrointestinal and Nervous System domains. These effects often manifest more frequently at the initiation of treatment or following an increase in dosage, typically resolving during continued use.

Classification Examples of Officially Documented Adverse Reactions
Very Common (ge 10%) Nausea, Diarrhea
Common (ge 1% to <10%) Insomnia, Vomiting, Muscle Cramps, Dizziness, Fatigue, Headache
Uncommon (ge 0.1% to <1%) Bradycardia (Slow Heart Rate), Seizures, Gastrointestinal Bleeding, Peptic Ulcer Disease

Serious Safety Considerations

Official prescribing information highlights the potential for Serious Adverse Reactions, which include the possibility of Bradycardia and Heart Block (due to effects on the sinoatrial and atrioventricular nodes), Gastrointestinal Bleeding, and Generalized Convulsions (Seizures). Rare cases of Rhabdomyolysis and Liver Dysfunction, including hepatitis, have also been reported.

Landex is contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. Safety monitoring considerations exist for individuals with Hepatic Impairment, as drug clearance may be decreased in this population.

Overdose and Emergency Response

Overdosage with Landex (donepezil) can result in a Cholinergic Crisis, which is characterized by severe overstimulation of the body's cholinergic system. Officially documented manifestations include severe nausea and vomiting, excessive salivation and sweating, bradycardia (slow heartbeat), hypotension, and increasing muscle weakness. Regulators emphasize that significant muscle weakness may lead to respiratory depression and death if the respiratory muscles are affected.

Severe, life-threatening outcomes listed in regulatory documents include Heart Block and convulsions (seizures). Post-marketing reports also note the risk of QTc interval prolongation and Torsade de Pointes. Individuals with low body weight may have an increased risk of toxicity.

Immediate medical attention is required if an overdose is suspected. Government guidance strongly advises to get emergency help at once and to call emergency services if symptoms include collapse, trouble breathing, or a seizure. Treatment described in labeling involves administering tertiary anticholinergics such as Atropine to reverse the toxic cholinergic effects, along with general supportive measures. Due to the medicine’s long half-life, close and prolonged monitoring in a hospital setting is necessary.

Therapeutic Uses of Landex

Landex Treats: Main Uses and Benefits

Landex (donepezil) is a supportive medication generally applied in the long-term management of cognitive symptoms associated with dementia, primarily Alzheimer’s disease across its mild, moderate, and severe stages. It is used to help improve mental function and provide support for symptom control. This includes use in conditions presenting with disruptive symptom manifestations, such as Alzheimer's disease dementia, and may be considered relevant in other contexts such as Parkinson’s disease dementia or vascular dementia.

“The use of the medication is considered relevant to support cognitive capacities during progressive manifestations.”

Supporting Core Thinking and Functional Stability

Landex is applied in addressing symptom clusters that interfere with daily functioning, such as memory loss, impaired attention, and difficulties in performing Activities of Daily Living (ADL). The use of Landex assists with maintaining functional stability and contributes to improved comfort during periods of heightened symptoms and supports general well-being during symptomatic phases.

Quick Fact: Relief for Cognitive Decline
Landex assists with preserving cognitive stability, making it relevant in clinical settings that involve progressive symptom patterns in older adults.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Landex (donepezil) eligibility is determined by specific regulatory criteria concerning allergies, age, organ function, and pre-existing medical conditions, as defined by governmental health authorities.

Contraindications and Prohibited Use

Eligibility Status Populations Prohibited From Use
Absolute Contraindication Patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives (the drug class) [SmPC, FDA Label].
Not Recommended Children and adolescents below 18 years of age; safety and efficacy have not been established [SmPC, FDA Label].
Not Recommended Pregnant women and nursing mothers (breastfeeding) due to unknown risk and insufficient human data [SmPC].
Avoid Use Concomitant use with other acetylcholinesterase inhibitors [Medsafe].

Conditional Use and Restrictions

Adults are the approved patient population for the labeled indication. However, regulatory documents mandate caution and special monitoring for certain groups:

  • Organ Function: No dosage adjustment is typically required for renal impairment. For mild to moderate hepatic impairment, dose escalation must be carefully monitored based on individual tolerability [SmPC]. There is no established data for patients with severe hepatic impairment [SmPC].
  • Comorbidities: Caution is advised for patients with cardiac conduction conditions (e.g., sick sinus syndrome) and those with a history of peptic ulcer disease, asthma, or obstructive pulmonary disease [FDA Label, NIH StatPearls].

These official statements define the eligibility framework, establishing who may use the medicine and under what regulatory conditions.

What should I know about interactions with other medicines?

Landex, an angiotensin-converting enzyme (ACE) inhibitor, can interact with various other medications, which may alter its effectiveness or increase the risk of serious side effects. It is critical to inform your healthcare provider of all prescription, over-the-counter medicines, vitamins, and herbal supplements you are taking.

Medications with Potential for Interaction

Drug Class Examples of Possible Interaction Risk/Effect
Diuretics (Water Pills) Hydrochlorothiazide, Furosemide Can cause an excessive drop in blood pressure (hypotension).
Potassium-Sparing Diuretics and Potassium Supplements Spironolactone, Amiloride, Potassium-containing salt substitutes Significantly increases the risk of high potassium levels (hyperkalemia), which can lead to abnormal heart rhythms.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ibuprofen, Naproxen Can reduce the blood-pressure-lowering effect of Landex and increase the risk of kidney function problems, especially in dehydrated or elderly patients.
Lithium Used for bipolar disorder Landex can decrease the removal of lithium from the body, leading to potentially toxic lithium levels.
Other Blood Pressure Medications Angiotensin Receptor Blockers (ARBs), Aliskiren Combining these is generally not recommended as it increases the risk of kidney problems, low blood pressure, and hyperkalemia.
Diabetes Medications (Oral agents and Insulin) Metformin, Insulin Glargine May increase the risk of low blood sugar (hypoglycemia).

Regular monitoring, including blood tests for potassium and kidney function, may be necessary when Landex is taken with certain interacting agents. Alcohol consumption should be discussed with a doctor, as it can worsen the blood pressure-lowering effect of Landex and increase the risk of side effects.

Mechanism of Action

Targeted Enzyme Inhibition and Acetylcholine Modulation

The mechanism of Landex (Donepezil) is a targeted, enzyme-mediated action that serves to augment chemical signaling within the brain, focusing exclusively on the cholinergic system. The core mechanistic domain involves the highly selective, reversible inhibition of the enzyme Acetylcholinesterase (AChE). This molecular action prevents AChE from rapidly breaking down the key neurotransmitter Acetylcholine (ACh), thereby increasing the concentration and prolonging the activity of ACh within the synaptic clefts.


Augmentation of Central Cholinergic Signaling

The sustained, elevated level of Acetylcholine (ACh) results in a functional augmentation of central cholinergic neurotransmission. This leads to amplified signaling across the neural networks, resulting in an overall increase in central cholinergic tone, which modulates the physiological output of circuits associated with cholinergic processing.


Mechanistic Constraints

This enzyme-preserving mechanism is inherently limited because its action is dependent on the continued presence and functionality of presynaptic cholinergic neurons to release the neurotransmitter. Since the drug only preserves existing acetylcholine, it increases signal transduction efficiency but does not engage in mechanisms that reverse or modify the underlying neuronal degradation.

Dosage and Administration Information

How to Use Landex: Administration Guidelines

Landex (donepezil hydrochloride) is administered via the oral route as a once-daily dose. Guidelines for its use involve a structured approach to ensure proper administration and gradual dose adjustment, a process known as titration.

Approved Forms and Intake Instructions

The medication is available as film-coated tablets (5 mg, 10 mg, 23 mg) and Orally Disintegrating Tablets (ODTs) (5 mg, 10 mg). The dose is taken in the evening, just prior to retiring (bedtime), and can be administered with or without food. Standard film-coated tablets, particularly the 23 mg strength, are to be swallowed whole and are not split, crushed, or chewed. ODTs are placed on the tongue to dissolve.

Standard Dosing and Titration Schedule

Treatment begins with a low starting dose to assess tolerability, followed by a slow increase to the maintenance dose.

Regimen Step Dose and Frequency Required Duration at Previous Dose
Starting Dose 5 mg once daily N/A
First Titration (to 10 mg) 10 mg once daily At least 4 to 6 weeks on 5 mg
**Second Titration (to 23 mg)*** 23 mg once daily At least 3 months on 10 mg

*The 23 mg dose is available in some regions for moderate to severe disease, while the maximum recommended dose in other regions is 10 mg once daily.

Special Use Conditions

Treatment is initiated and overseen by a physician experienced in managing the condition, and therapy is continued as long as clinical benefit is maintained. For patients with renal impairment, a similar dose schedule can be followed. The medicine is not recommended for use in children and adolescents under 18 years of age.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Research on Joint Function and Pain

Studies evaluated whether Landex might affect joint function and explored a potential reduction in pain in individuals with chronic joint conditions. Research has examined the potential for a reduction in swelling across various study populations.

  • Phase 1 Trials: Initial safety and dosing trials focused on healthy volunteers. Research protocols specified the compound's administration parameters in these studies.
  • Phase 2 Trials (Exploration): These trials explored whether a pain relief effect could be observed. A key trial involving 150 participants found that individuals receiving the compound reported changes in their pain levels over a 12-week period.

Research on Inflammation Markers

Research examined Landex's relationship with inflammatory markers. Research investigated the compound's exploration in relation to early-stage inflammation.

  • Specific Marker Focus: Several preclinical studies focused on the compound's association with the C-Reactive Protein (CRP). These studies evaluated the compound's presence in plasma and its relationship to changes in CRP levels.
  • Combination Therapies: Studies have evaluated whether the combination is associated with changes in mobility, compared to monotherapy. This research involved participants whose inclusion criteria required specific mobility challenges.

Safety Profile Research

Study designs focused on adults without pre-existing condition X. Specific populations were excluded from the trial design, including individuals with severe liver or kidney impairment. Study protocols included recording all adverse events.

  • Long-term Data: Evidence remains limited regarding effects beyond the 6-month period of the primary clinical trials. Research protocols did not include long-term data to assess effects over several years.

In summary, research has explored the compound's potential association with chronic joint issues. Further research is planned to expand on initial observations.

Key Studies & References

  1. Randomized Controlled Trial of Exercise Therapy in Combination With Central Nervous System-targeted Treatment Compared With Exercise Therapy Alone for Treatment of People With Knee Osteoarthritis (NCT03681613)

Frequently Asked Questions (FAQ)

Common questions about Landex (FAQ)


Q: Is Landex known to cause problems with sleep?

Official prescribing information lists insomnia (trouble sleeping) as a common side effect reported in clinical trials. This effect is often related to the medicine's activity and is one of the more frequently observed reactions.


Q: Are the side effects of Landex permanent?

According to official documents, common side effects, especially gastrointestinal reactions like nausea and vomiting, are often described as transient. This means they are described as generally resolving during the continuation of the medicine.


Q: What do official documents say about Landex and alcohol use?

Official prescribing information advises that the matter of alcohol consumption should be discussed with a doctor. This caution is noted because alcohol may worsen the medicine's blood pressure-lowering effect and increase the risk of certain side effects.


Q: Can Landex interact with common pain relievers like ibuprofen?

Regulatory documents note a potential interaction with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen. The use of Landex with NSAIDs may increase the risk of gastrointestinal bleeding.


Q: How long does Landex stay in your system after stopping it?

Landex has an elimination half-life of approximately 70 hours, which is about three days. Because of this, it takes several days for the medicine to be largely cleared from the body after the last dose is taken.


Q: How is Landex usually stored at home?

According to official regulatory requirements, the medicine must be stored at Controlled Room Temperature (68°F to 77°F or 20°C to 25°C). It is required to be kept in its original, tightly closed container and out of the sight and reach of children.


Q: What happens if I miss a dose of Landex?

Official guidance indicates that if a single dose is missed, the next dose is typically taken at the regular time. Official patient information indicates that if several doses are missed, consultation with a physician is necessary before treatment is resumed.


Q: Can Landex be crushed or split?

The standard film-coated tablets must be swallowed whole and should not be split, crushed, or chewed. The Orally Disintegrating Tablets (ODTs) are specifically designed to dissolve directly on the tongue.


Q: Can people over 65 usually take Landex?

Landex is approved for use in the adult population. Studies performed to date have not identified geriatric-specific problems that would limit the product's application in this population.


Q: Why is Landex sometimes referred to as a 'targeted' therapy?

This term is related to the medicine's function as an Acetylcholinesterase Inhibitor. The mechanism is described as a highly selective, reversible inhibition of a specific enzyme, focusing its action exclusively on augmenting the chemical signaling in the cholinergic system.


Q: How quickly should I expect Landex to start working?

The medicine reaches its peak concentration in the bloodstream approximately 3 to 4 hours after a single dose. Consistent levels in the body, known as steady-state concentration, are generally reached after 15 to 21 days of daily dosing.


Q: What is the longest time someone typically takes Landex?

Regulatory documents state that therapy should be continued only as long as clinical benefit is maintained. Therapy is generally managed by a physician who evaluates the ongoing continuation of the medicine.


Q: Does Landex cause weight changes, like gain or loss?

Official prescribing information reported weight loss as an adverse reaction in a percentage of patients participating in clinical studies. This was particularly observed in patients taking the higher 23 mg dose of the medicine.


Q: Can Landex interact with vitamins or herbal supplements?

Regulatory information notes that the herbal supplement St. John's wort may lower the concentration of Landex in the blood. Official information stresses the importance of informing a physician about all herbal remedies, vitamins, or supplements being taken.


Q: Does Landex have a high risk of withdrawal symptoms?

Official drug labeling notes that following discontinuation, the beneficial effects of the medicine will gradually diminish over approximately six weeks. This abatement of effects is described as occurring without evidence of a rebound effect.


Q: Is Landex a type of antibiotic or steroid?

Landex is officially classified as a prescription-only medicine that is a centrally acting, reversible Acetylcholinesterase Inhibitor (AChEI). It belongs to a specific pharmacological class and is not categorized as an antibiotic or a steroid.


Q: What is the difference between Landex and a placebo in studies?

Clinical studies have examined the functional difference between Landex and a placebo (an inactive treatment). Results indicated that the medicine provided modest benefits in terms of measured outcomes related to cognition or behavior compared to the placebo group.


Q: What type of research evidence supports the use of Landex?

Research evidence supporting the medicine includes Phase 2 trials that explored potential effects of the compound. Clinical reviews have verified the medicine's role as an Acetylcholinesterase Inhibitor in supporting cognitive capacity in relevant contexts.


Q: Does Landex have a risk of causing dependence?

Based on official clinical data and reporting, no habit-forming tendency has been reported in relation to the use of Landex.


Q: Can Landex affect the results of a routine blood test?

Landex does not require routine laboratory testing before initiation. However, blood tests for potassium and kidney function may be necessary when the medicine is taken concurrently with certain interacting medications.


Q: What are the signs that Landex is working effectively?

The medicine's mechanism is broadly aimed at supporting fundamental processes related to memory and thinking abilities. Assessment of whether the medicine is fulfilling its intended purpose is typically a clinical judgment, and continuation of therapy is based on whether the clinical benefit is maintained.


Q: What is the typical age range of people who use Landex?

Landex is approved for use exclusively in the adult population. Official information explicitly states that its safety and efficacy have not been established for use in children and adolescents below 18 years of age.


Q: Can Landex affect my driving or ability to operate machinery?

Regulatory warnings note that the medicine may cause some people to become dizzy or drowsy, or experience blurred vision. It is important for patients to be aware of their reaction to the medicine before driving or operating machinery.


Q: Is there any research on Landex use in children or teenagers?

The safety and efficacy of Landex have not been established for use in children and adolescents below 18 years of age. For this reason, official use in these populations is not recommended.


Q: Is Landex designed to cure the condition, or just manage symptoms?

Landex is officially intended for the symptomatic treatment of the condition it is approved for. Regulatory context indicates that there is no evidence to suggest that it modifies or alters the underlying progression of the disease.


Q: Can Landex cause skin reactions or rashes?

Landex is contraindicated (prohibited) in patients with a known hypersensitivity to the active ingredient or to piperidine derivatives. Hypersensitivity reactions may manifest as conditions like skin rashes.


Q: What if I'm taking Landex and need a surgery or dental procedure?

Official documents warn that Landex, as a cholinesterase inhibitor, is likely to exaggerate certain types of muscle relaxation used during anesthesia. It is recommended that any healthcare professional be informed that you are taking Landex before having surgery or a dental procedure.


Q: Why do people sometimes stop taking Landex?

Common reasons for discontinuation noted in clinical data include the abatement (loss) of clinical benefit from the medicine. Another common reason is the occurrence of unmanageable side effects, particularly gastrointestinal reactions like nausea and vomiting.


Q: What are the most commonly reported side effects of Landex in clinical trials?

According to official prescribing information, the most commonly reported adverse reactions in clinical studies are nausea, diarrhea, insomnia (trouble sleeping), vomiting, muscle cramps, fatigue, and headache.


Q: Do I need any special monitoring while taking Landex?

Regulatory documents advise that regular monitoring may be necessary when Landex is taken with certain interacting agents. This monitoring can include blood tests for potassium and kidney function.


Q: Why is my doctor starting me on a certain dose of Landex?

Official prescribing guidelines dictate that treatment begins with a low starting dose to initially assess tolerability of the medicine. Following initiation, the medicine is typically advanced through a slow, gradual increase to the maintenance dose, according to the official titration schedule.

How should Landex be stored and disposed of?

Landex (donepezil) must be stored and disposed of strictly according to official regulatory requirements to ensure product quality and safety.

Item Official Regulatory Requirement
Labeled storage temperature Store at Controlled Room Temperature, 68 F to 77 F (20 C to 25 C).
Light/moisture protection Protect from excess moisture, humidity, and direct light.
Handling requirement Keep from freezing and avoid excess heat. Keep in original container, tightly closed.
Disposal instructions Utilize a drug take-back program. If unavailable, mix with an undesirable substance (e.g., dirt) in a sealed container and dispose of in household trash. Do not flush.
Child-protection storage Keep out of the sight and reach of children and young children.

Regulatory documents explicitly define the required thermal environment, prohibiting freezing to preserve the tablets. The profile mandates using the original, tightly closed packaging for protection from moisture and light. Furthermore, official labeling requires mandatory child-safety storage and specific disposal procedures for unused or expired medicine, favoring formal collection over simple disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Landex found in:

A-Z Index: